Skip to main content
. 2013 Jun 14;32(2):66–71. doi: 10.1016/j.krcp.2013.05.001

Figure 1.

Figure 1

Urinary excretions of VEGF-C in patients with CKD stage 3–4 (CKD stages 3 and 4) and healthy control subjects (Control). (A) Urine levels of VEGF-C per urine creatinine in patients with CKD stage 3–4 and healthy control subjects. (B) Fractional excretion of VEGF-C in patients with CKD stage 3–4 and healthy control subjects. *P < 0.05 versus control. CKD, chronic kidney disease; VEGF-C, vascular endothelial growth factor.